SML0437
氧雄龙
≥98% (HPLC)
别名:
17β-羟基-17α-甲基-2-氧杂-5α--雄烷-3-酮, 8075CB, NSC 67068, SC 11585, 奥克西伦, 氧甲氢龙
质量水平
方案
≥98% (HPLC)
表单
powder
旋光性
[α]/D -19 to -26°, c = 1 (CDCl3)
药品控制
USDEA Schedule IIIN; regulated under CDSA - not available from Sigma-Aldrich Canada
颜色
white to beige
溶解性
DMSO: 2 mg/mL (clear solution; warmed)
储存温度
2-8°C
SMILES字符串
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C
InChI
1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1
InChI key
QSLJIVKCVHQPLV-PEMPUTJUSA-N
基因信息
human ... AR(367)
正在寻找类似产品? 访问 产品对比指南
警示用语：
Danger
危险声明
危险分类
Carc. 2 - Repr. 1B
储存分类代码
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
Susan R Rose et al.
Pediatric blood & cancer, 61(1), 11-19 (2013-09-11)
A majority of Fanconi anemia (FA) patients will experience bone marrow failure (BMF) and androgen therapy (most often oxymetholone) may be utilized as a treatment to improve BMF-related cytopenias. However, oxymetholone is associated with toxicities making identification of other agents
Gerd G Gauglitz et al.
Current opinion in clinical nutrition and metabolic care, 14(2), 176-181 (2010-12-16)
The hypermetabolic response in critically ill patients is characterized by hyperdynamic circulatory, physiologic, catabolic and immune system responses. Failure to satisfy overwhelming energy and protein requirements after, and during critical illness, results in multiorgan dysfunction, increased susceptibility to infection, and
Kim Freriks et al.
European journal of endocrinology, 168(1), 91-99 (2012-10-19)
Short stature is a prominent feature of Turner syndrome (TS), which is partially overcome by GH treatment. We have previously reported the results of a trial on the effect of oxandrolone (Ox) in girls with TS. Ox in a dose
Clinical practice. Short stature in childhood--challenges and choices.
David B Allen et al.
The New England journal of medicine, 368(13), 1220-1228 (2013-03-29)
Rhonda Orr et al.
Drugs, 64(7), 725-750 (2004-03-18)
There has been increasing interest in the development of effective agents that can be safely used to promote anabolism in the clinical setting for patients with chronic wasting conditions as well as in the prevention and treatment of frailty associated
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持